To determine the relationship between mitochondrial DNA haplogroups and the incidence of diabetes mellitus (DM) in men with and without HIV, and to explore interactions with mitochondrial-toxic antiretroviral therapy (ART), highlighting the significance of these findings in the context of existing research.
Key Findings:
African mtDNA haplogroup L3 was associated with a higher risk of incident DM in men with HIV (HR, 1.92; 95% CI, 1.19–3.10).
Exposure to mitochondrial-toxic ART (D-drugs) was independently associated with an increased risk of DM (HR, 2.8; 95% CI, 1.5–5.3).
Interpretation:
Mitochondrial genetic variability, particularly haplogroup L3, and exposure to certain ART significantly influence the risk of developing DM in men with HIV, suggesting important implications for clinical practice.
Limitations:
Study focused only on men, limiting generalizability to women.
Potential confounding factors may not have been fully accounted for, including biases in self-reported data.
Conclusion:
The findings highlight the importance of mitochondrial genetics and ART exposure in assessing diabetes risk among men with HIV, suggesting a need for tailored diabetes prevention strategies in this population, such as monitoring and managing mitochondrial health.
by Craig Cronin, Todd T Brown, Hsing-Yu Hsu, David C Samuels, Weiqun Tong, Sudipa Sarkar, Alison G Abraham, Jeremy J Martinson, Shehnaz K Hussain, Steven Wolinsky, Todd Hulgan, Jing Sun
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
